Myeloid derived suppressor cell(MDSC)-targeted immunotherapy for oral cancer
Project/Area Number |
23890069
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Surgical dentistry
|
Research Institution | University of Toyama |
Principal Investigator |
TOMIHARA Kei 富山大学, 大学病院, 医員 (70404738)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 口腔癌 / マウスモデル / ミエロイド系抑制性細胞 |
Research Abstract |
In a mouse model of oral cancer, accumulation of myeloid derived suppressor cells(MDSC) was observed in the tumor tissue, and this attenuation of MDSC was ameliorated by low dose gemcitabine administration.
|
Report
(3 results)
Research Products
(7 results)